Clovis Oncology, Inc. reports

Company location: Boulder, CO
Fiscal year end: 31 December

Clovis Oncology, Inc. has filed 952 SEC EDGAR filings since 25 Jun 2009

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 476-500 of 951 matching filings.

Per page

25

Current page

20

FWP File 333-215400

FWP

Filing date: 17 Apr 2018
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

FWP File 333-215400

FWP

Filing date: 17 Apr 2018
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

FWP File 333-215400

FWP

Filing date: 16 Apr 2018
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

424B5 File 333-215400

424(B)(5)

Filing date: 16 Apr 2018
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

424B5 File 333-215400

424(B)(5)

Filing date: 16 Apr 2018
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

POSASR File 333-215400

POSASR

Filing date: 16 Apr 2018
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-35347

8-K

Filing date: 10 Apr 2018
Reporting date: 09 Apr 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 09 Apr 2018
Reporting date: 09 Apr 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 21 Mar 2018
Reporting date: 20 Mar 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 21 Mar 2018
Reporting date: 20 Mar 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 09 Mar 2018
Reporting date: 08 Mar 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 09 Mar 2018
Reporting date: 07 Mar 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 09 Mar 2018
Reporting date: 07 Mar 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 09 Mar 2018
Reporting date: 07 Mar 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 07 Mar 2018
Reporting date: 06 Mar 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 02 Mar 2018
Reporting date: 01 Mar 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 02 Mar 2018
Reporting date: 01 Mar 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 02 Mar 2018
Reporting date: 01 Mar 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 02 Mar 2018
Reporting date: 01 Mar 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 02 Mar 2018
Reporting date: 01 Mar 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 02 Mar 2018
Reporting date: 01 Mar 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 02 Mar 2018
Reporting date: 01 Mar 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

10-K File 001-35347

10-K

Filing date: 27 Feb 2018
Reporting date: 31 Dec 2017
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-35347

CLOVIS ONCOLOGY, INC. 8-K

Filing date: 26 Feb 2018
Reporting date: 26 Feb 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 23 Feb 2018
Reporting date: 22 Feb 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .